Job Seekers, Welcome to Regulatory Career Connections
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 84 Jobs
Save Agent
Loading... Please wait.
Kimberly-Clark Logo
Kimberly-Clark

Neenah, Wisconsin

Siemens Healthineers Logo
Siemens Healthineers

Tarrytown, New York

Endologix Logo
Endologix

Santa Rosa/Irvine, California

Endologix Logo
Endologix

Irvine, California

Summit Medical, LLC Logo
Summit Medical, LLC

Eagan, Minnesota

United Therapeutics Corporation

RTP, North Carolina

Kindred Hospitals Logo
Kindred Hospitals

Seattle, Washington

NEW! NEW!
CHRISTUS Health Logo
CHRISTUS Health

Texarkana, Texas

NEW! NEW!
Stanford Children's Health - Lucile Packard Children's Hospital Logo
Stanford Children's Health - Lucile Packard Children's Hospital

Palo Alto, California

Kindred Hospitals Logo
Kindred Hospitals

Ft. Lauderdale, Florida

Kindred Hospitals Logo
Kindred Hospitals

Langhorne, Pennsylvania

MultiCare Health System Logo
MultiCare Health System

Olympia, Washington

AdventHealth Logo
AdventHealth

Tampa, Florida

Kindred Hospitals Logo
Kindred Hospitals

Madison, New Jersey

CHRISTUS Health Logo
CHRISTUS Health

Corpus Christi, Texas

AdventHealth Logo
AdventHealth

Oviedo, Florida

CARTI

Little Rock, Arkansas

CHRISTUS Health Logo
CHRISTUS Health

San Antonio, Texas

TMF Health Quality Instutute

Nationwide

CHRISTUS Health Logo
CHRISTUS Health

San Antonio, Texas

CHRISTUS Health Logo
CHRISTUS Health

Corpus Christi, Texas

Kindred Hospitals Logo
Kindred Hospitals

Franklin, Tennessee

Kindred Hospitals Logo
Kindred Hospitals

Perris, California

Geisinger Logo
Geisinger

Muncy, Pennsylvania

Loading... Please wait.
Manager/Senior Manager, Regulatory Affairs
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, USA – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b


This job listing is no longer active.

Check the left side of the screen for similar opportunities.
Loading. Please wait.
Powered By Naylor Association Solutions
For assistance please call 888.491.8833 or e-mail candidatesupport@naylor.com